Patient-perceived progression in multiple system atrophy: natural history of quality of life
Authors:
- Tiphaine SaulnierTSTiphaine Saulnier
- Margherita FabbriMFMargherita Fabbri
- Mélanie Le GoffMGMélanie Le Goff
- Catherine HelmerCHCatherine Helmer
- Anne Pavy-Le TraonATAnne Pavy-Le Traon
- Olivier RascolOROlivier Rascol
- Cécile Proust-LimaCPCécile Proust-Lima
Preprint
Abstract
Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improving patient care, and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly documented, as for multiple system atrophy (MSA), a rare and rapidly progressing alpha-synucleinopathy. This work aimed to describe Hr-QoL progression during the natural course of MSA, explore disparities between patients, and identify informative items using a four-step statistical strategy.We leveraged the data of the French MSA cohort comprising annual assessments with the MSA-QoL questionnaire for more than 500 patients over up to 11 years. The four-step strategy (1) determined the subdimensions of Hr-QoL in MSA; (2) modelled the subdimension trajectories over time, accounting for the risk of death; (3) mapped the sequence of item impairments with disease stages; and (4) identified the most informative items specific to each disease stage.Among the 536 patients included, 50% were women and they were aged on average 65.1 years old at entry. Among them, 63.1% died during the follow-up. Four dimensions were identified. In addition to the original motor, nonmotor, and emotional domains, an oropharyngeal component was highlighted. While the motor and oropharyngeal domains deteriorated rapidly, the nonmotor and emotional aspects were already slightly to moderately impaired at cohort entry and deteriorated slowly over the course of the disease. Impairments were associated with sex, diagnosis subtype, and delay since symptom onset. Except for the emotional domain, each dimension was driven by key identified items.Hr-QoL is a multidimensional concept that deteriorates progressively over the course of MSA and brings essential knowledge for improving patient care. As exemplified with MSA, the thorough description of Hr-QoL using the 4-step original analysis can provide new perspectives on neurodegenerative diseases' management to ultimately deliver better support focused on the patient's perspective.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5LBrain and Behavior, 2022
- Disease progression and prognostic factors in multiple system atrophy: A prospective cohort studyNeurobiology of Disease, 2020
- Multiple System Atrophy: Recent Developments and Future PerspectivesMovement Disorders, 2019
- Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up studyActa Neurologica Belgica, 2018
- Sleep Abnormalities in MultipleSystem AtrophyCurrent Treatment Options in Neurology, 2018
- Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear PalsyParkinsonism & Related Disorders, 2017
- Validation of the French version of the MSA health-related Quality of Life scale (MSA-QoL)Revue Neurologique, 2013
- Assessment of quality of life with the multiple system atrophy health‐related quality of life scaleMovement Disorders, 2012
- Measuring health‐related quality of life in MSA: The MSA‐QoLMovement Disorders, 2007
- Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)Movement Disorders, 2004